Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Sexually Transmitted Diseases

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 74 articles:
HTML format
Text format



Single Articles


    September 2017
  1. MALAGON T, Burchell AN, El-Zein M, Guenoun J, et al
    Estimating HPV DNA deposition between sexual partners using HPV concordance, Y chromosome DNA detection, and self-reported sexual behaviours.
    J Infect Dis. 2017 Sep 9. doi: 10.1093.
    PubMed     Text format     Abstract available


  2. RYSER MD, Rositch A, Gravitt PE
    Modeling of US Human Papillomavirus (HPV) Seroprevalence by Age and Sexual Behavior Indicates an Increasing Trend of HPV Infection Following the Sexual Revolution.
    J Infect Dis. 2017;216:604-611.
    PubMed     Text format     Abstract available


  3. OLIVER SE, Unger ER, Lewis R, McDaniel D, et al
    Prevalence of Human Papillomavirus Among Females After Vaccine Introduction-National Health and Nutrition Examination Survey, United States, 2003-2014.
    J Infect Dis. 2017;216:594-603.
    PubMed     Text format     Abstract available


    August 2017
  4. LEHTINEN T, Soderlund-Strand A, Petaja T, Eriksson T, et al
    Human papillomavirus (HPV) prevalence in adolescent males four years post HPV16/18 vaccination.
    J Infect Dis. 2017 Aug 24. doi: 10.1093.
    PubMed     Text format     Abstract available


  5. DE POKOMANDY A, Kaufman E, de Castro C, Mayrand MH, et al
    The EVVA Cohort Study: Anal and Cervical Type-Specific Human Papillomavirus Prevalence, Persistence, and Cytologic Findings in Women Living With HIV.
    J Infect Dis. 2017;216:447-456.
    PubMed     Text format     Abstract available


  6. BAUSSANO I, Lazzarato F, Ronco G, Lehtinen M, et al
    Different Challenges in Eliminating HPV16 Compared to Other Types: A Modeling Study.
    J Infect Dis. 2017;216:336-344.
    PubMed     Text format     Abstract available


    July 2017
  7. LEWIS J, Price MJ, Horner PJ, White PJ, et al
    Genital Chlamydia trachomatis Infections Clear More Slowly in Men Than Women, but Are Less Likely to Become Established.
    J Infect Dis. 2017;216:237-244.
    PubMed     Text format     Abstract available


  8. GOLDEN MR, Workowski KA, Bolan G
    Developing a Public Health Response to Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  9. MCGOWIN CL, Totten PA
    The Unique Microbiology and Molecular Pathogenesis of Mycoplasma genitalium.
    J Infect Dis. 2017;216.
    PubMed     Text format     Abstract available


  10. HAMPRAS SS, Rollison DE, Giuliano AR, McKay-Chopin S, et al
    Prevalence and Concordance of Cutaneous Beta Human Papillomavirus Infection at Mucosal and Cutaneous Sites.
    J Infect Dis. 2017;216:92-96.
    PubMed     Text format     Abstract available


    June 2017
  11. HUANG LM, Puthanakit T, Cheng-Hsun C, Ren-Bin T, et al
    Sustained Immunogenicity of 2-dose Human Papillomavirus 16/18 AS04-adjuvanted Vaccine Schedules in Girls Aged 9-14 Years: A Randomized Trial.
    J Infect Dis. 2017 Jun 7. doi: 10.1093.
    PubMed     Text format     Abstract available


  12. QENDRI V, Bogaards JA, Berkhof J
    Health and economic impact of a tender-based gender-neutral HPV16/18 vaccination program in the Netherlands.
    J Infect Dis. 2017 Jun 6. doi: 10.1093.
    PubMed     Text format     Abstract available


    May 2017
  13. JORDAN SJ, Olson KM, Barnes S, Wilson LS, et al
    Lower Levels of Cervicovaginal Tryptophan are Associated with Natural Clearance of Chlamydia in Women.
    J Infect Dis. 2017 May 17. doi: 10.1093.
    PubMed     Text format     Abstract available


  14. STEINAU M, Gorbach P, Gratzer B, Braxton J, et al
    Concordance between Anal and Oral Human Papillomavirus (HPV) Infections Among Young Men Who Have Sex with Men.
    J Infect Dis. 2017 May 15. doi: 10.1093.
    PubMed     Text format     Abstract available


    April 2017
  15. BAKSHI R, Gupta K, Jordan SJ, Brown LT, et al
    Immunoglobulin-Based Investigation of Spontaneous Resolution of Chlamydia trachomatis Infection.
    J Infect Dis. 2017 Apr 21. doi: 10.1093.
    PubMed     Text format     Abstract available


  16. PATEL EU, Rositch AF, Gravitt PE, Tobian AAR, et al
    Concordance of Penile and Oral Human Papillomavirus Infections Among Men in the United States.
    J Infect Dis. 2017;215:1207-1211.
    PubMed     Text format     Abstract available


    March 2017
  17. SUCHLAND RJ, Dimond ZE, Putman TE, Rockey DD, et al
    Whole-genome sequencing of repeat-positive, same-serovar Chlamydia trachomatis collected from the female genital tract demonstrate persistent infections and genome stability.
    J Infect Dis. 2017 Mar 23. doi: 10.1093.
    PubMed     Text format     Abstract available


  18. KOTTARIDI C, Kyrgiou M, Pouliakis A, Magkana M, et al
    Quantitative Measurement of L1 Human Papillomavirus Type 16 Methylation for the Prediction of Preinvasive and Invasive Cervical Disease.
    J Infect Dis. 2017;215:764-771.
    PubMed     Text format     Abstract available


    February 2017
  19. SHANNON B, Gajer P, Yi TJ, Ma B, et al
    Distinct effects of the cervico-vaginal microbiota and herpes simplex type 2 infection on female genital tract immunology.
    J Infect Dis. 2017 Feb 13. doi: 10.1093.
    PubMed     Text format    


  20. RODAS PI, Perez D, Jauffret C, Gonzalez Y, et al
    Modified Profile of Matrix Metalloproteinase 2 and 9 Production by Human Fallopian Tube Epithelial Cells After Infection In Vitro With Neisseria gonorrhoeae.
    J Infect Dis. 2017;215:452-455.
    PubMed     Text format     Abstract available


    January 2017
  21. BERNSTEIN DI, Wald A, Warren T, Fife K, et al
    Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings from a Randomized Trial.
    J Infect Dis. 2017 Jan 30. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  22. FLORES-DIAZ E, Sereday KA, Ferreira S, Sirak B, et al
    HPV-6 molecular variants association with the development of genital warts in men: The HIM Study.
    J Infect Dis. 2016 Dec 23. pii: jiw600. doi: 10.1093.
    PubMed     Text format     Abstract available


  23. DONKEN R, Schurink-van 't Klooster TM, Schepp RM, van der Klis FR, et al
    Immune responses after two- versus three-doses of HPV vaccination up to 4(1/2) years post vaccination: an observational study among Dutch routinely vaccinated girls (HPV2D).
    J Infect Dis. 2016 Dec 23. pii: jiw588. doi: 10.1093.
    PubMed     Text format     Abstract available


  24. HEARD I, Tondeur L, Arowas L, Demazoin M, et al
    Effectiveness of HPV vaccination on prevalence of vaccine genotypes in young sexually active women in France.
    J Infect Dis. 2016 Dec 23. pii: jiw639. doi: 10.1093.
    PubMed     Text format     Abstract available


  25. GRABOWSKI MK, Gravitt PE, Gray RH, Serwadda D, et al
    Trends and determinants of human papillomavirus concordance among HIV-positive and HIV-negative heterosexual couples in Rakai, Uganda.
    J Infect Dis. 2016 Dec 23. pii: jiw631. doi: 10.1093.
    PubMed     Text format     Abstract available


  26. MESQUITA PM, Preston-Hurlburt P, Keller MJ, Vudattu N, et al
    Role of IL-32 in HIV Reactivation and its Link to HIV-HSV Coinfection.
    J Infect Dis. 2016 Dec 22. pii: jiw612. doi: 10.1093.
    PubMed     Text format     Abstract available


  27. GEORGE Z, Omosun Y, Azenabor AA, Partin J, et al
    The roles of unfolded protein response pathways in Chlamydia pathogenesis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2016
  28. BERENSON AB, Laz TH, Rahman M
    Reduction in vaccine-type human papillomavirus prevalence among adult females in the United States, 2009-2012.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  29. MACHALEK DA, Chow EP, Garland SM, Wigan R, et al
    Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  30. SCHLECHT NF, Diaz A, Shankar V, Szporn AH, et al
    RISK OF DELAYED HPV VACCINATION IN INNER-CITY ADOLESCENT WOMEN.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  31. RUSSELL AN, Zheng X, O'Connell CM, Wiesenfeld HC, et al
    Identification of Chlamydia trachomatis antigens recognized by T cells from highly exposed women who limit or resist genital tract infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  32. GRAD YH, Harris SR, Kirkcaldy RD, Green AG, et al
    Genomic epidemiology of gonococcal resistance to extended spectrum cephalosporins, macrolides, and fluoroquinolones in the US, 2000-2013.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  33. REIMERS LL, Mehta SD, Massad LS, Burk RD, et al
    The Cervicovaginal Microbiota and Its Associations with Human Papillomavirus (HPV) Detection in HIV-Infected and HIV-Uninfected Women.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  34. PINTO LA, Kemp TJ, Torres BN, Isaacs K, et al
    THE QUADRIVALENT HPV VACCINE INDUCES HPV-SPECIFIC ANTIBODIES AT THE ORAL CAVITY: RESULTS FROM THE MID-ADULT MALE VACCINE TRIAL-THE MAM TRIAL.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  35. PAMNANI SJ, Nyitray AG, Abrahamsen M, Rollison DE, et al
    Sequential acquisition of anal HPV infection following genital infection among men who have sex with women: the HPV Infection in Men (HIM) Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  36. MATTHIJSSE SM, Hontelez JA, Naber SK, Rozemeijer K, et al
    Public health benefits of routine human papillomavirus vaccination for adults in the Netherlands: a mathematical modeling study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  37. MEITES E, Gorbach PM, Gratzer B, Panicker G, et al
    Monitoring for HPV Vaccine Impact among Gay, Bisexual and other Men who have Sex with Men - United States, 2012-2014.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  38. PRICE MJ, Ades AE, Welton NJ, Simms I, et al
    Proportion of Pelvic Inflammatory Disease Cases Caused by Chlamydia trachomatis: Consistent Picture From Different Methods.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  39. TOTA JE, Ramanakumar AV, Villa LL, Richardson H, et al
    Cervical Infection with Vaccine Human Papillomavirus (HPV) Genotypes as a Predictor of Acquisition and Clearance of Other HPV Infections.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  40. LAPRISE JF, Markowitz LE, Chesson HW, Drolet M, et al
    COMPARING 2- AND 3-DOSE 9-VALENT HPV VACCINE SCHEDULES IN THE U.S.: A COST-EFFECTIVENESS ANALYSIS.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  41. MILMAN N, Zhu J, Johnston C, Cheng A, et al
    In Situ Detection of Regulatory T Cells in Human Genital Herpes Simplex Virus Type 2 (HSV-2) Reactivation and Their Influence on Spontaneous HSV-2 Reactivation.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    March 2016
  42. GRAVITT PE, Marks M, Kosek M, Huang C, et al
    Soil-Transmitted Helminth Infections Are Associated With an Increase in Human Papillomavirus Prevalence and a T-Helper Type 2 Cytokine Signature in Cervical Fluids.
    J Infect Dis. 2016;213:723-30.
    PubMed     Text format     Abstract available


    February 2016
  43. PIERCE CAMPBELL CM, Viscidi RP, Torres BN, Lin HY, et al
    Human papillomavirus (HPV) L1 serum antibodies and risk of subsequent oral HPV acquisition in men: The HIM Study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  44. D'SOUZA G, Wentz A, Kluz N, Zhang Y, et al
    Gender differences in risk factors and natural history of oral human papillomavirus (HPV) infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  45. CHESSON HW, Laprise JF, Brisson M, Markowitz LE, et al
    The Impact and Cost-Effectiveness of 3 doses of 9-Valent Human Papillomavirus (HPV) Vaccine among US Females Previously Vaccinated with 4-Valent HPV Vaccine.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  46. MEYS R, Purdie KJ, de Koning MN, Quint KD, et al
    HLA immunogenotype determines persistent HPV infection in anti-retroviral treated HIV.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  47. PUTHANAKIT T, Huang LM, Chiu CH, Tang RB, et al
    A randomised open trial comparing 2-dose regimens of the HPV-16/18 AS04-adjuvanted vaccine in girls aged 9-14 years versus 3 doses in women aged 15-25 years.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    January 2016
  48. RADZIO J, Henning T, Jenkins L, Ellis S, et al
    Combination emtricitabine and tenofovir disoproxil fumarate prevents vaginal SHIV infection in macaques harboring C. trachomatis and T. vaginalis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    December 2015
  49. FIFE KH, Mugwanya K, Thomas KK, Baeten JM, et al
    Transient Increase in HSV-2-Associated Genital Ulcers Following Initiation of Antiretroviral Therapy in HIV-1/HSV-2 Co-Infected Individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  50. BEACHLER DC, Jenkins G, Safaeian M, Kreimer AR, et al
    Natural acquired immunity against subsequent genital HPV infection: a systematic review and meta-analysis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  51. HEARD I, Poizot-Martin I, Potard V, Etienney I, et al
    Prevalence of and risk factors for Anal Oncogenic human papillomavirus infection among HIV-Infected Women in France in the cART era.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  52. SCHILLER JT, Lowy DR
    Reply to Nalin.
    J Infect Dis. 2015;212:2021-2.
    PubMed     Text format    


  53. MARRA CM, Tantalo LC, Sahi SK, Dunaway SB, et al
    Treponema pallidum-specific Opsonic Antibody Activity is Reduced in HIV-Infected Patients with Syphilis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    November 2015
  54. GRABOWSKI MK, Kong X, Gray RH, Serwadda D, et al
    Partner human papillomavirus viral load and incident human papillomavirus detection in heterosexual couples.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    October 2015
  55. HARARI A, Chen Z, Rodriguez AC, Hildesheim A, et al
    Cross-protection of the bivalent human papillomavirus (HPV) vaccine against variants of genetically related high-risk HPV infections.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  56. GRAD YH, Goldstein E, Lipsitch M, White PJ, et al
    Improving control of antibiotic resistant gonorrhea by integrating research agendas across disciplines: key questions arising from mathematical modeling.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  57. PHIPPS W, Nakku-Joloba E, Krantz EM, Selke S, et al
    Genital Herpes Simplex Virus Type 2 Shedding Among Adults With and Without HIV Infection in Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  58. LOW AJ, Nagot N, Weiss HA, Konate I, et al
    Herpes simplex virus type-2 (HSV-2) cervico-vaginal shedding among women living with HIV-1 on antiretroviral therapy in Burkina Faso: an 8-year longitudinal study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  59. RUSSELL AN, Zheng X, O'Connell CM, Taylor BD, et al
    Analysis of factors driving incident and ascending infection and the role of serum antibody in Chlamydia trachomatis genital tract infection.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    August 2015
  60. GRAVITT PE
    HPV Seroprevalence in the United States: Behavior, Biology, and Prevention.
    J Infect Dis. 2015.
    PubMed     Text format    


  61. LIU G, Markowitz LE, Hariri S, Panicker G, et al
    Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  62. NALIN DR
    Single-Dose Vaccines.
    J Infect Dis. 2015.
    PubMed     Text format    


  63. CONLEY LJ, Bush TJ, Darragh TM, Palefsky JM, et al
    Incidence and Predictors For Development of Abnormal Anal Cytology Among HIV-infected Adults Receiving Contemporary Antiretroviral Therapy.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  64. ELFSTROM KM, Lazzarato F, Franceschi S, Dillner J, et al
    Human papillomavirus vaccination of boys and extended catch-up vaccination: Effects on the resilience of programs.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    June 2015
  65. DUNNE EF, Naleway A, Smith N, Crane B, et al
    Reduction in HPV vaccine type prevalence among young women screened for cervical cancer in an integrated health care delivery system, United States 2007, 2012-2013.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  66. MANAM S, Thomas JD, Li W, Maladore A, et al
    Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8+ T Cells and TNF Receptor Superfamily Member 1a on Non-CD8+ T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection.
    J Infect Dis. 2015;211:2014-22.
    PubMed     Text format     Abstract available


  67. BENDER IGNACIO RA, Perti T, Magaret AS, Rajagopal S, et al
    Oral and gel tenofovir for genital HSV-2 shedding in immunocompetent women: a double-blind randomized cross-over trial (128/160 chars&spaces).
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    May 2015
  68. BEACHLER DC, Guo Y, Xiao W, Burk RD, et al
    High oral HPV16 viral load predicts long-term persistence in HIV-infected and at risk HIV-uninfected individuals.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  69. GRABOWSKI MK, Kigozi G, Gray RH, Armour B, et al
    HSV-2 shedding from male circumcision wounds in Rakai, Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  70. HAMPRAS SS, Giuliano AR, Lin HY, Fisher KJ, et al
    Natural history of polyomaviruses in men: the HPV infection in men (HIM) study.
    J Infect Dis. 2015;211:1437-46.
    PubMed     Text format     Abstract available


    March 2015
  71. GIANELLA S, Redd AD, Grabowski MK, Tobian AA, et al
    Vaginal Cytomegalovirus Shedding before and after Initiation of Antiretroviral Therapy in Rakai, Uganda.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  72. MULLER K, Kazimiroff J, Fatahzadeh M, Smith RV, et al
    Oral Human Papillomavirus and Oral Lesions In HIV-positive and HIV-negative Dental Patients.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  73. NYITRAY AG, Chang M, Villa LL, Carvalho da Silva RJ, et al
    The natural history of genital human papillomavirus among HIV-negative men having sex with men and men having sex with women.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    January 2015
  74. ESBER A, Vicetti Miguel RD, Cherpes TL, Klebanoff M, et al
    Risk of bacterial vaginosis among women with herpes simplex virus type 2 infection: a systematic review and meta-analysis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Sexually Transmitted Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: